Clinical Research Studies

Search our active and enrolling clinical research studies and see if you may qualify to participate.

NASA

coronary artery disease

The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.

MT1002

acute coronary syndrome

To evaluate the feasibility and safety of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation.

LEADR

tachyarrhythmia

The study is designed to assess the safety and efficacy of the Next Generation ICD lead.

INTREPID TMVR

severe, symptomatic mitral regurgitation

PILOT: The study is pilot trial to evaluate the safety and performance of the Twelve TMVR System in very high-risk mitral regurgitation patients.

EFS: The study is an EFS trial to evaluate the safety and performance of the Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal access in patients with severe, symptomatic mitral regurgitation.

HORIZON

established heart disease and elevated lipoprotein(a)

This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated lipoprotein(a).

Questions about research options? Contact us.

Sign Up For Our Newsletter

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.